ZC0109
ZC0109 is a dual inhibitor of IDO1 and thioredoxin reductase 1 (TrxR1) with IC50s of 50 nM and 3.0 μM, respectively. ZC0109 induces ROS accumulation and cell cycle arrest at G1/S phase, thus leads to cancer cells apoptosis[1].
Product Specifications
CAS Number
3037850-79-3
UNSPSC
12352005
Target
Apoptosis; Indoleamine 2,3-Dioxygenase (IDO)
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zc0109.html
Concentration
10mM
Purity
99.32
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O/N=C(C1=NON=C1NCCCC2=NN=C(S2)NC(CC3=CC=C(C=C3)O)=O)\NC4=CC(Br)=C(C=C4)F
Molecular Formula
C22H20BrFN8O4S
Molecular Weight
591.41
References & Citations
[1]Zhou J, et al. Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors. Eur J Med Chem. 2023 Jan 5;245 (Pt 1) :114860.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
T-6601-1 1 mg
Texas Red Conjugated Cicer arietinum Lectin (Chick Pea) -CPA-
Sign In for Pricing
View Details 
![ARL11 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1E1]](https://cdn.genprice.uk/products/937/68dd1b6d061270361ea16d7b/imageurl/ta503905bm.webp)
TA503905BM 100 µL
ARL11 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1E1]
Sign In for Pricing
View Details 
